Welcome to our dedicated page for Wns Hldgs SEC filings (Ticker: WNS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The WNS (Holdings) Limited SEC filings archive provides a regulatory record of the company’s life as a publicly traded issuer on the New York Stock Exchange under the symbol WNS and its subsequent transition into a wholly owned subsidiary of Capgemini S.E. As a digital-led business transformation and services company in the data processing and hosting space, WNS used its SEC reports to disclose financial performance, risk factors, and material events.
Investors and researchers can review periodic reports such as annual reports on Form 10-K and quarterly reports on Form 10-Q (when available) to analyze WNS’s revenue, profit, cash flows, and balance sheet, as well as management’s discussion and analysis of its operations. These filings are particularly relevant for understanding how WNS described its digital-led services, client base, and global delivery footprint over time.
The archive also includes current reports on Form 8-K that document key corporate events. In 2025, a series of 8-K filings detailed the announcement of the proposed acquisition by Capgemini, publication of the scheme document, recommendations from proxy advisory firms, shareholder approval of the scheme of arrangement, receipt of regulatory clearances, sanction of the scheme by the Royal Court of Jersey, and, on October 17, 2025, completion of the transaction that made WNS a wholly owned subsidiary of Capgemini.
Two additional filings are central to WNS’s trading status. A Form 25 filed on October 17, 2025, by the New York Stock Exchange initiated the removal of WNS ordinary shares from listing and registration under Section 12(b) of the Exchange Act. Subsequently, a Form 15 filed on October 27, 2025, certified the termination of registration of WNS’s ordinary shares under Section 12(g) and the suspension of its reporting obligations under Sections 13 and 15(d). The Form 15 notes that there was one holder of record as of the certification date.
On Stock Titan, these filings can be paired with AI-powered summaries that explain the structure and implications of documents such as 8-Ks, Form 25, and Form 15 in clear language. This helps users quickly understand how WNS’s regulatory disclosures reflect its shift from a listed NYSE company to a private subsidiary within Capgemini, while still allowing detailed review of the original SEC documents when needed.
FIL Limited and affiliates updated their ownership in WNS Holdings Ltd. In an amended Schedule 13G/A (Amendment No. 1), FIL Limited reported beneficial ownership of 0.00 shares, representing 0.0% of WNS common stock as of 10/31/2025. The filing lists 0.00 for sole and shared voting power and for sole and shared dispositive power.
Pandanus Partners, L.P. and Pandanus Associates, Inc. each separately reported beneficial ownership of 0.00 shares, or 0.0% of the class, with no voting or dispositive power. The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
WNS (Holdings) Ltd filed a Form 25 indicating removal of its Ordinary Shares from listing and/or registration under Section 12(b) of the Securities Exchange Act on the New York Stock Exchange LLC.
The notice cites 17 CFR 240.12d2-2(b) (exchange-initiated strike from listing) and 17 CFR 240.12d2-2(c) (issuer voluntary withdrawal) as the governing provisions.
WNS (Holdings) Limited announced completion of its acquisition by Capgemini S.E. via a Jersey scheme of arrangement. At the Effective Time, each ordinary share was exchanged for $76.50 per share in cash, without interest and subject to tax withholding.
Outstanding and vested RSUs, plus 20% of each unvested RSU tranche (performance RSUs at maximum), were cancelled for cash based on the $76.50 price, less applicable withholdings. Remaining unvested RSUs were amended to pay cash upon the original service-based vesting schedule at the same per-share price. Trading in WNS shares on the NYSE was halted before market open on the Closing Date, and the company requested NYSE to file Form 25 to delist. After Form 25 becomes effective, WNS intends to file Form 15 to deregister and suspend Exchange Act reporting. The scheduled annual general meeting on October 30, 2025 is cancelled, and board changes were made consistent with the transaction.
WNS (HOLDINGS) LTD announced that it entered into a Transaction Agreement with Capgemini S.E. on
WNS (Holdings) Limited has scheduled its annual general meeting of shareholders for October 30, 2025 and has released the related materials. The company issued a press release and distributed the meeting notice, proxy statement, proxy card and voting card, which are included as exhibits to this report. The filing also references a proposed acquisition by Capgemini S.E. of the entire issued and to be issued share capital of WNS through a court-approved scheme of arrangement under Jersey law, noting that this transaction may complete before the scheduled meeting time.
WNS (Holdings) Ltd. reported that on July 7, 2025 it entered into a Transaction Agreement with Capgemini S.E. for Capgemini to acquire the company by a scheme of arrangement under Jersey law. The filing notes a press release is attached as Exhibit 99.1 and incorporated by reference. The Transaction requires customary approvals, including court approval and a shareholder meeting to satisfy an additional closing condition. The notice is signed by General Counsel Gopi Krishnan on September 17, 2025.
FIL Limited, together with Pandanus Partners, L.P. and Pandanus Associates, Inc., reports beneficial ownership of 4,682,087 shares of WNS HLDGS LTD common stock, representing 10.9% of the class. FIL Limited discloses 4,665,534 shares as sole voting power and 4,682,087 as sole dispositive power; the Pandanus entities report sole dispositive power for the same amount and no shared voting or dispositive power. The filing states these securities are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. The filing references an Exhibit 99 agreement and a previously filed power of attorney.
WNS (Holdings) Limited reported that its shareholders approved the previously announced transaction under which Capgemini S.E. will acquire the entire issued and to be issued share capital of WNS through a court-approved scheme of arrangement under Jersey law.
At the Court Meeting, 39 shareholders representing 34,052,325 ordinary shares were present in person or by proxy out of 42,993,190 shares outstanding as of the voting record time, giving about 79.20% participation. The Scheme proposal received 34,049,641 votes in favor and 2,684 against, or 99.99% versus 0.01% of votes cast.
At the General Meeting, 34,052,529 ordinary shares were represented, again about 79.20% of shares entitled to vote. The proposal authorizing the directors to take actions to carry the Scheme into effect and amending the articles of association received 33,940,965 votes for and 2,596 against, with 108,968 votes withheld, meeting the required two-thirds approval threshold. WNS also issued a press release announcing shareholder approval of the transaction.
WNS (Holdings) Limited filed a report describing developments related to its planned acquisition by Capgemini S.E., which is expected to be carried out through a court-approved scheme of arrangement under Jersey law. The company announced that independent proxy advisory firms Institutional Shareholder Services (ISS) and Glass Lewis have both recommended that WNS shareholders vote “FOR” the Scheme and related proposals.
These recommendations apply to the upcoming Court Meeting and General Meeting of WNS shareholders scheduled for August 29, 2025. WNS also reminds shareholders to review the previously filed Scheme Document and related SEC materials before voting, and notes that the transaction will proceed solely on the terms set out in the Transaction Agreement and the Scheme.